Ipsen SA (IPN)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA and an Investment Account

Sell

€101.50

Buy

€104.10

arrow-down€-1.90 (-1.82%)

Prices updated at 13 May 2025, 16:35 CEST

Prices minimum 15 mins delay

Prices in EUR

Ipsen SA is a pharmaceutical company. The company mainly develops and manufactures products to serve the oncology, endocrinology, neurosciences, and primary care areas mainly across the European markets.

FTSE EuroFirst 300

0.09%

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Chairman

Mr. Antoine Flochel

CEO

Mr. David Loew

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

5,358

Head office

70 rue Balard

Paris

France

75015

+33 158335000

investor.relations@ipsen.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Dr. Margaret A. Liu, M.D. Independent Director	-
Ms. Karen Witts Independent Director	-
Ms. Carol Xueref Director	-
Dr. Piet Wigerinck, PhD Independent Director	-
Mr. David Loew Director and Chief Executive Officer	-
Dr. Pascal Touchon, D.V.M. Independent Director	-
Mr. Marc de Garidel Chairman of the Board	-
Mr. Antoine Flochel Vice Chairman of the Board	-
Ms. Anne Beaufour Director	-
Mr. Henri Beaufour Director	-
Mr. Philippe Bonhomme Director	-
Ms. Laetitia Ducroquet Director, Deputy Chief Business Ethics Officer and Vice President, Global Business Ethics	-
Ms. Michele Ollier Director	-
Ms. Naomi Binoche Director and Vice President, Strategic Alliances Management	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Vanguard Group Inc	985,104
Grantham, Mayo, Van Otterloo & Co., LLC	956,873
GMO Intl Op Value Composite	906,476
BlackRock Fund Advisors	769,834
ODDO BHF Asset Management SAS	720,839

Director dealings

Date chevron-l-regular chevron-r-regular	Action
No data

Please note that past performance is not a reliable indicator of future returns.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.